Medicare Enrolled

Dr. Matthew McMenemy, MD

Glaucoma Specialist (Ophthalmology) Physician · Sugar Land, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
3515 TOWN CENTER BLVD S, Sugar Land, TX 77479
2812778400
In practice since 2006 (19 years)
NPI: 1700842267 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McMenemy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McMenemy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McMenemy

Dr. Matthew McMenemy is a glaucoma specialist (ophthalmology) physician in Sugar Land, TX, with 19 years in practice. Based on federal Medicare data, Dr. McMenemy performed 14,756 Medicare services across 9,011 unique beneficiaries.

Between the years covered by Open Payments, Dr. McMenemy received a total of $212,233 from 41 pharmaceutical and/or device companies across 682 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in glaucoma specialist (ophthalmology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McMenemy is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 4% volume in TX$ $212,233 industry payments

Medicare Practice Summary

Medicare Utilization ↗
14,756
Medicare services
Top 4% in TX for glaucoma specialist (ophthalmology) physician
9,011
Unique beneficiaries
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~777 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Measurement of corneal pressure4,030$8$25
Comprehensive eye exam, established patient3,269$81$243
Eye exam, established patient, focused1,356$61$125
Retinal imaging (OCT scan)1,316$27$167
Visual field test, extended845$42$170
Retinal photography (fundus photo)677$25$147
Corneal topography and eye depth measurement634$18$145
Optic nerve imaging (OCT scan)629$23$168
Comprehensive eye exam, new patient342$90$292
Eye injection for retinal disease219$87$240
Aflibercept eye injection (Eylea)196$687$1,329
Cataract surgery with lens implant180$404$1,795
Removal of recurring cataract in lens capsule using a laser168$247$685
Ultrasound scan of cornea to determine thickness164$7$44
Injection, bevacizumab, 10 mg131$54$105
Ct scan of cornea124$24$174
Extended exam involving color vision testing102$40$75
Extended exam of the back part of the eye with retinal drawing85$16$92
Exam to measure eye deviation and range of motion54$45$120
Closure of tear duct opening using plug44$118$364
Extended exam of the back part of the eye with optic nerve drawing42$11$75
Removal of eye fluid37$92$574
Removal of eyelashes using forceps35$13$189
Probing of nasal tear duct23$122$417
Photography of content of eyes21$12$88
New patient problem focused exam of visual system18$51$149
Removal of growth of eyelid15$195$627
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
18.8% medium
79.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$212,233
Total received (2018-2024)
Avg $30,319/year across 7 years
Top 3% in TX for glaucoma specialist (ophthalmology) physician
41
Companies
682
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$191,675 (90.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,056 (5.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,732 (3.6%)
Other
Charitable contributions, space rental, and other categories
$770 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$25,164
2023
$11,411
2022
$21,198
2021
$22,624
2020
$5,211
2019
$33,751
2018
$92,873

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Bausch & Lomb, a division of Bausch Health US, LLC
$105,242
Bausch & Lomb Americas Inc.
$49,473
Novartis Pharmaceuticals Corporation
$30,076
Aerie Pharmaceuticals, Inc.
$6,026
Kala Pharmaceuticals, Inc.
$4,772
Regeneron Pharmaceuticals, Inc.
$2,450
Johnson & Johnson Surgical Vision, Inc.
$2,246
Alcon Vision LLC
$1,420
ABBVIE INC.
$1,383
Alcon Laboratories Inc
$1,264
Eyevance Pharmaceuticals LLC
$1,094
Sun Pharmaceutical Industries Inc.
$915
Carl Zeiss Meditec USA, Inc.
$804
Allergan, Inc.
$626
Horizon Therapeutics plc
$487
Allergan Inc.
$457
Shire North American Group Inc
$427
Sight Sciences, Inc.
$372
Oyster Point Pharma, Inc.
$365
Tarsus Pharmaceuticals, Inc.
$240
Harrow Eye, LLC
$239
Regeneron Healthcare Solutions, Inc.
$215
Glaukos Corporation
$188
TissueTech, Inc.
$176
BIOTISSUE HOLDINGS INC.
$157
Incyte Corporation
$153
Ocular Therapeutix, Inc.
$126
Amgen Inc.
$118
Thea Pharma Inc.
$117
SUN PHARMACEUTICAL INDUSTRIES INC.
$111
Beaver-Visitec International, Inc.
$83
Dompe US, Inc.
$79
Mallinckrodt Hospital Products Inc.
$69
Astellas Pharma US Inc
$64
Johnson & Johnson Vision Care, Inc.
$57
Optos, Inc.
$32
Mallinckrodt Enterprises LLC
$24
TISSUETECH, INC.
$23
RECORDATI_RARE_DISEASES_INC.
$22
CooperVision Inc.
$19
RxSight Inc
$19
Top 3 companies account for 87.1% of total payments
Associated products mentioned in payments ›
ACTHAR · ALREX · ARGOS · AcrySof · AcrySof IQ PanOptix · AcrySof IQ VIVITY IOL · Acuvue · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Centurion · Cequa · Clareon · Clariti Contact Lens · CyPass · DEXTENZA · DUREZOL · DURYSTA · EYLEA · EYLEA HD · EYSUVIS · Flarex · HYDRUS Microstent · INVELTYS · ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM · IYUZEH · Izervay · LOTEMAX · LOTEMAX SM · LUMERA · LUMERA 300 · LUMIGAN · LenSx · MIEBO · NEOX · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OPZELURA · OXERVATE · PANHEMATIN · PANORAMIC OPHTHALMOSCOPE · PAZEO · PROLENSA · Prokera · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · Rhopressa · Rocklatan · Simbrinza · TEARCARE SYSTEM · TENEO · TEPEZZA · TRAVATAN Z · TYRVAYA · TearCare · TearCare SmartLid · TearScience Activators · Tecnis 1-piece IOL · Tecnis IOL · Tecnis Simplicity · Tecnis Symfony IOL · Tobradex ST · VEVYE · VICTUS · VUITY · VYZULTA · Winlevi · XDEMVY · XELPROS · XEN GLAUCOMA TREATMENT SYSTEM · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (90%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in glaucoma specialist (ophthalmology) physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for glaucoma specialist (ophthalmology) physician in TX.

Equivalent to $1,438 per 100 Medicare services performed
Looking for a glaucoma specialist (ophthalmology) physician in Sugar Land?
Compare glaucoma specialist (ophthalmology) physicians in the Sugar Land area by procedure volume, costs, and industry payment transparency.
Browse glaucoma specialist (ophthalmology) physicians nearby

Geographic Context

Glaucoma Specialist (Ophthalmology) Physicians within 10 mi
8
Per 100K population
0.9
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. McMenemy is a mixed practice specialist, with above-average Medicare volume (top 4% in TX), and high industry engagement (speaking/promotional, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. McMenemy experienced with measurement of corneal pressure?
Based on Medicare claims data, Dr. McMenemy performed 4,030 measurement of corneal pressure services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McMenemy receive payments from pharmaceutical companies?
Yes. Dr. McMenemy received a total of $212,233 from 41 companies across 682 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McMenemy's costs compare to other glaucoma specialist (ophthalmology) physicians in Sugar Land?
Dr. McMenemy's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McMenemy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →